Aztreonam Amide | CAS 1219444-93-5 - Request Quote
Aztreonam Amide
| SZ CAT No: | SZ-A072008 |
| CAS No | 1219444-93-5 |
| Mol.F. | C13H20N6O8S2 |
| Mol.Wt. | 452.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Aztreonam Amide is chemically 2-(2-(((1-Amino-2-methyl-1-oxopropan-2-yl)oxy)imino)-2-(2-aminothiazol-4-yl)acetamido)-3-(sulfoamino)butanoic acid. Aztreonam Amide is supplied with detailed characterization data compliant with regulatory guideline. Aztreonam Amide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aztreonam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1219444-93-5
Purchase 1219444-93-5
Order 1219444-93-5
Enquire 1219444-93-5
price of 1219444-93-5
1219444-93-5 Supplier
1219444-93-5 Manufacturer
1219444-93-5 Exporter
buy high quality Aztreonam Amide
Purchase Aztreonam Amide
Aztreonam Amide suppliers
Aztreonam Amide manufacturers
Aztreonam Amide price
Order Aztreonam Amide
Enquire Aztreonam Amide
Aztreonam Amide cost
Aztreonam Amide Supplier
Aztreonam Amide Distributor
Aztreonam Amide for Method Validation
Aztreonam Reference Standard
Aztreonam Amide for ANDA Filing
Aztreonam Amide for Forced Degradation Studies
Aztreonam Amide Identification Standards
Aztreonam Amide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.